This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Dr. Feng Peng, PhD
Principal Scientist at Merck
Speaker

Profile

Feng Peng joined Merck & Co., Inc., Rahway, NJ in 2012 (Recruited by Tao Pei 😊) after receiving his Ph.D. with Professor Samuel Danishefsky from Columbia University. His research at Merck focuses on using organic chemistry innovations to accelerate drug development and reduce the environmental footprint. Feng was the 2019/2021 EPA Green Chemistry Challenge Awardee, ACS 2021 Young Investigator Awardee, and 2023 ACS GCI Peter J. Dunn Awardee. He currently leads the ACS Green Chemistry Institute Pharmaceutical Roundtable Supply Chain Team and is an active member of the ACS GCI PR Peptide Team to promote Green Chemistry Innovations in the field of peptide manufacturing.

Agenda Sessions

  • Synthesis of Non-Canonical Amino Acids (NCAA) Through Biocatalysis

    9:10am